- Home
- IFBD vs ADXN Comparison
IFBD vs ADXN Comparison
Compare IFBD & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFBD
- ADXN
- Stock Information
- Founded
- IFBD 2001
- ADXN 2002
- Country
- IFBD China
- ADXN Switzerland
- Employees
- IFBD N/A
- ADXN N/A
- Industry
- IFBD Computer Software: Prepackaged Software
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- IFBD Technology
- ADXN Health Care
- Exchange
- IFBD Nasdaq
- ADXN Nasdaq
- Market Cap
- IFBD 8.4M
- ADXN 8.1M
- IPO Year
- IFBD 2021
- ADXN N/A
- Fundamental
- Price
- IFBD $1.05
- ADXN $9.00
- Analyst Decision
- IFBD
- ADXN Strong Buy
- Analyst Count
- IFBD 0
- ADXN 1
- Target Price
- IFBD N/A
- ADXN $30.00
- AVG Volume (30 Days)
- IFBD 23.4K
- ADXN 7.6K
- Earning Date
- IFBD 01-01-0001
- ADXN 06-19-2025
- Dividend Yield
- IFBD N/A
- ADXN N/A
- EPS Growth
- IFBD N/A
- ADXN N/A
- EPS
- IFBD N/A
- ADXN 0.10
- Revenue
- IFBD $1,437,848.00
- ADXN $278,508.00
- Revenue This Year
- IFBD N/A
- ADXN $86.57
- Revenue Next Year
- IFBD N/A
- ADXN N/A
- P/E Ratio
- IFBD N/A
- ADXN $0.74
- Revenue Growth
- IFBD 413.52
- ADXN N/A
- 52 Week Low
- IFBD $0.89
- ADXN $6.51
- 52 Week High
- IFBD $3.54
- ADXN $13.27
- Technical
- Relative Strength Index (RSI)
- IFBD 50.08
- ADXN 55.39
- Support Level
- IFBD $1.00
- ADXN $8.02
- Resistance Level
- IFBD $1.06
- ADXN $9.78
- Average True Range (ATR)
- IFBD 0.05
- ADXN 0.73
- MACD
- IFBD 0.01
- ADXN 0.02
- Stochastic Oscillator
- IFBD 35.71
- ADXN 32.94
About IFBD Infobird Co. Ltd
Infobird Co Ltd is engaged in developing and providing customer engagement cloud-based services. It software-as-a-service provider of AI-powered, or artificial intelligence-enabled, customer engagement solutions in China. It provides holistic software solutions to help corporate clients proactively deliver and manage end-to-end customer engagement activities at all stages of the sales process, including pre-sales and sales activities, and post-sales customer support. It also offers AI-powered cloud-based sales force management software, including intelligent quality inspection and intelligent training software to help clients monitor, benchmark, and improve the performance of agents.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.